ATP-sensitive potassium (K ATP )1 channels are inwardly rectifying potassium channels, which are inhibited by ATP and stimulated by MgADP (1-3). They play important roles by linking cellular metabolic level to membrane potential by sensing intracellular ATP and ADP levels in various tissues such as pancreatic -cells, heart, brain, skeletal muscle, and vascular smooth muscle. The K ATP channel is a hetero-octamer composed of sulfonylurea receptor (SURx) and Kir6.x subunits in 4:4 stoichiometry (4 -7). SURx is a member of the ATP-binding cassette (ABC) superfamily including P-glycoprotein (MDR1), multidrug resistance-associated protein (MRP1), and the cystic fibrosis transmembrane conductance regulator (CFTR) (8, 9), all of which have two nucleotide-binding folds (NBFs) per molecule; Kir6.x is a member of the inwardly rectifying potassium channel family (10 -12). Both SURx and Kir6.x have a number of subtypes as follows: SUR1, SUR2A, and SUR2B and Kir6.1 and Kir6.2. SUR1 has been cloned as a high affinity binding protein for sulfonylurea (9), the most commonly used drug for treatment of patients with type 2 diabetes. SUR2A shares 68% amino acid identity with SUR1, and SUR2B is a splicing variant of SUR2A differing only in its C-terminal 42 amino acids (13,14). The Cterminal 42 amino acids of SUR2B are similar to those of SUR1. Kir6.1 and Kir6.2 share 71% amino acid identity with each other, both of which have two putative transmembrane domains and an ion pore-forming (H5) region.Pancreatic -cell K ATP channels, composed of SUR1 and Kir6.2, regulate insulin secretion by altering the -cell membrane potential (1,3,15,16). Coexpression of SUR2A/Kir6.2, SUR2B/Kir6.2, and SUR2B/Kir6.1 has been reported to reconstitute cardiac, smooth muscle, and vascular smooth muscle K ATP channels, respectively (2, 3). These channels have different sensitivities to ATP and show different responses to sulfonylurea drugs and potassium channel openers (10,11,14,17,18). The IC 50 (ATP) of SUR1/Kir6.2 K ATP channels is about 10 M, whereas those of SUR2A/Kir6.2 and SUR2B/Kir6.2 are about 100 and 300 M, respectively (10,11,14). SUR2B/Kir6.1 K ATP channels are not inhibited by ATP but are stimulated by ADP and ATP (17). SUR1/Kir6.2 K ATP channels are inhibited by glibenclamide at K i ϳ10 nM, and SUR2A/Kir6.2, SUR2B/ Kir6.2, and SUR2B/Kir6.1 K ATP channels are inhibited with K i values in the low micromolar range (10,11,14,17). Both SUR1/Kir6.2 and SUR2B/Kir6.2 K ATP channels are stimulated by diazoxide, but SUR2A/Kir6.2 K ATP channels are not (10,11,14). The differences between these channels may be caused, at least in part, by differences in SUR subtype. However, it is not clear how SUR subtypes cause the different properties of K ATP channel subtypes.We have already shown that NBF1 of SUR1 is a Mg 2ϩ -independent high affinity ATP-binding site, that NBF2 is a Mg 2ϩ -dependent low affinity ATP-binding site, and that MgADP binding at NBF2 stabilizes the 8-azido-ATP binding at